• Home
  • Top Stories
  • Markets
  • Market Data
  • Companies
  • Opinion
  • Economy & Policy
  • Finance
  • Politics
  • Technology
  • Personal Finance
  • Current Affairs
  • International
  • Management
  • Weekend
  • General News
  • Latest News
  • Today's Paper
  • Videos
  • Covid-19
  • Portfolio
  • Login

Patanjali
DMA takes exception to IMA criticism of Harsh Vardhan over Coronil event
Won't allow sale of Coronil without certification: Maharashtra minister
Shocked at Patanjali's 'blatant lie of WHO certification', says IMA
Never certified any traditional medicine as a cure for Covid-19: WHO
Patanjali's Coronil, 1st 'proof-based' drug to fight Covid, gets govt nod

Pure controversy
Patanjali's Ruchi Soya to launch follow-on offering next year: Swami Ramdev
Patanjali Ayurved far from glory days even as revenue and profit rise
India Coronavirus Dispatch: How safe is your data with Aarogya Setu?
Delhi High Court defers hearing in petitions against NAA to December 7

Sebi proposes to increase minimum free float for firms post-insolvency
India's bond market is so hot even Yoga guru Ramdev is selling debt
IPL 2020 title sponsorship: Tata, Jio, Patanjali among firms in the fray
IPL 2020: Edu-tech firm Unacademy set to fight for title sponsorship rights
IPL 2020: BCCI invites bids for title sponsorship rights by Friday
Madras HC maintains injunction barring Patanjali from using term Coronil
Baba Ramdev to set up gurukul on vedic culture and yoga in Ayodhya
From Patanjali's claim to U-turn on Coronil: Sequence of events
Coronil: Patanjali can sell its drug, but not as a cure for Covid-19
Ruchi Soya soared 90 times in 5 months; should you buy?
Next 
⇧ Back to Top
  • Top Stories
  • Markets
  • Market Data
  • Companies
  • Opinion
  • Economy & Policy
  • Finance
  • Politics
  • Technology
  • Personal Finance
  • Current Affairs
  • International
  • Budget 2021
  • Insurance Round Table 2020
View Full Site >>
Copyrights © 2021 Business Standard Private Ltd. All rights reserved